SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

ImmunityBio, Inc. is a clinical stage immunotherapy company. It develops next generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate and adaptive immune systems to create long term immunological memory. ImmunityBio was founded by Patrick Soon-Shiong in 2014 and is headquartered in San Diego, CA.

ImmunityBio Inc

ImmunityBios completion of the first German labeling and packaging run for ANKTIVA is driving attention, with traders viewing it as a tangible step toward European commercialization and potential international revenue. Bulls expect broader approvals and a short squeeze, while skeptics argue the rollouts financial impact remains unproven and cite cash burn, dilution, and continued volatility.

SoFi Technologies, Inc. is a financial service platform, which engages in the provision of student loan refinancing options to the private student loan market. It operates through the following segments: Lending, Technology Platform, and Financial Services. The Lending segment offers personal loans, student loans, home loan products, and related servicing activities. The Technology Platform segment focuses on technology products and solutions revenue. The Financial Services segment includes the SoFi Money product, SoFi Invest product, SoFi Credit Card product, SoFi Relay personal finance management product, and other financial services. The company was founded in April 2011 and is headquartered in San Francisco, CA.

SoFi Technologies Inc

Hawkish commentary from Fed official Kevin Warsh, including repeated references to inflation and possible rate hikes, has driven a broad selloff in fintech and other rate-sensitive stocks, with traders debating whether the move is macro-driven or amplified by options positioning. Bulls argue SoFis guidance already accounts for potential hikes and continue buying the dip, while bears cite its high rate sensitivity and weak price action.

lululemon athletica, Inc. engages in the business of designing, distributing, and retailing technical athletic apparel, footwear, and accessories. It operates through the following segments: Company-Operated Stores, Direct to Consumer, and Other. The company was founded by Dennis James Wilson in 1998 and is headquartered in Vancouver, Canada.

Lululemon Athletica inc.

Lululemon Athletica Inc

Anticipation of upcoming earnings, amplified by traders focus on reports that Michael Burry increased his LULU position, is driving attention. Bulls cite the potential impact of tariff refunds, the incoming CEO and low valuation, while bears remain concerned about weak consumer demand, competition and slowing U.S. and China sales.

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

A disclosed bearish BMF Capital short report criticizing SELLASs REGAL Phase 3 design, statistical power, dilution and valuation triggered the selloff and dominated discussion. Traders are divided between viewing it as a self-interested hit piece with no new clinical evidence and worrying that the delayed 80th event, quiet period and pending REGAL topline results could signal unfavorable data.

Affirm Holdings, Inc. operates a platform for digital and mobile-first commerce. Its platform consists of three core elements: a point-of-sale payment solution for consumers, merchant commerce solutions, and a consumer-focused app. The company was founded by Max R. Levchin in 2012 and is headquartered in San Francisco, CA.

Affirm Holdings Inc - Ordinary Shares - Class A

Affirm Holdings Inc

A strong quarterly earnings beat and better-than-expected outlook drove an initial surge in Affirm shares, while the sharp reversal drew debate over sell-the-news profit-taking, options-related trading, and broader rate concerns around the Feds Jackson Hole event. Bulls view the pullback as temporary despite solid growth, while bears see a recurring post-earnings fade and renewed credit-risk concerns.

Destiny Tech100, Inc. operates as a non-diversified, closed-end management investment company. The company was founded on November 18, 2020 and is headquartered in Austin, TX.

Destiny Tech100 Inc

DESTINY TECH 100 INC

Anticipation of a potential Anthropic IPO is driving attention, with traders viewing DXYZ as a major pre-IPO proxy because of its Anthropic exposure and expecting a re-rating alongside an updated NAV. The bullish case is tempered by debate over stale NAV disclosures, dilution, and whether the Anthropic SPV structure is valid, contributing to significant volatility and skepticism.

Reading International, Inc. is an entertainment and real estate company, which engages in the development, ownership, and operation of multiplex cinemas and retail and commercial real estate in the United States, Australia, and New Zealand. It operates through the Cinema Exhibition and Real Estate segments. The Cinema Exhibition segment includes Reading Cinemas, Angelika Film Center, Consolidated Theatres, City Cinemas, 44 Union Square, and Liberty Theatres brands. The Real Estate segment consists of real estate development and the rental or licensing of retail, commercial and live theater assets. The company was founded by James J. Cotter Sr. in 1999 and is headquartered in New York, NY.

Reading International Inc - Ordinary Shares - Class B

A sharp move in Reading Internationals thinly traded Class B shares has focused attention on low-float, short-squeeze and buyout speculation, with traders citing volatility, trading halts and limited share availability. Some also point to a reported earnings turnaround and the companys real-estate assets, while others warn the move may be a momentum-driven pump with selling pressure and no confirmed new catalyst.

Papa John's International, Inc. engages in the operation and franchise of pizza delivery and carryout restaurants. It operates through the following segments: Domestic Company-owned Restaurants, North America Franchising, North America Commissaries, International Operations, and All Others. The Domestic Company-Owned Restaurants segment consists of retail sales of pizza and side items, breadsticks, cheese sticks, chicken poppers and wings, dessert items, and canned and bottled beverages. The North America Franchising segment involves the offering of sales and support activities, development rights, and collection of royalties from franchisees located in the United States and Canada. The North America Commissaries segment includes the eleven full-service regional dough production and distribution and quality control centers. The International Operations segment represents all restaurant operations outside of the United States and Canada. The All Others segment focuses on franchise contributions to marketing funds and sale, company-owned and franchised restaurants, information systems and related services used in restaurant operations, point-of-sale system, online and other technology-based ordering platforms, printing, and promotional items. The company was founded by John H. Schnatter in 1984 and is headquartered in Louisville, KY.

Papa John`s International, Inc.

Renewed reports of a Qatari-backed Irth Capital take-private bid, supported by Papa Johns largest U.S. franchisee, are driving attention and fueling hopes for a premium acquisition and potential short covering. Traders remain divided, with bulls expecting a deal or activist pressure while skeptics cite weak same-store sales, debt, dividend suspension, and uncertainty over managements willingness to sell.

Chevron Corp. engages in the provision of oil and gas energy solutions. It provides crude oil and natural gas, manufactures transportation fuels, lubricants, petrochemicals, and additives, and develops technologies that enhance business and the industry. It operates through the Upstream and Downstream segments. The Upstream segment consists of the exploration, development, and production of crude oil and natural gas, the liquefaction, transportation, and regasification associated with liquefied natural gas, the transporting of crude oil by major international oil export pipelines, the processing, transporting, storage, and marketing of natural gas, and a gas-to-liquids plant. The Downstream segment consists of the refining of crude oil into petroleum products, the marketing of crude oil and refined products, the transporting of crude oil and refined products by pipeline, marine vessel, motor equipment, and rail car, and the manufacturing and marketing of commodity petrochemicals and plastics for industrial uses and fuel & lubricant additives. The company was founded on September 10, 1879 and is headquartered in Houston, TX.

Chevron Corp.

Chevron is trending as investors react to a significant 20-year power agreement with Microsoft to supply natural gas for AI data centers, while also weighing broader energy sector volatility driven by geopolitical tensions and fluctuating oil supply. Community discussion is focused on the company's long-term cash flow strength, the strategic pivot toward powering AI infrastructure, and mixed sentiments regarding the impact of ongoing Middle East instability on oil production.

Vera Therapeutics, Inc. is a clinical stage biotechnical company, which engages in the development and commercialization of transformative treatments for immunological diseases. Its product includes the TRUTAKNA injection. The company was founded by Marshall W. Fordyce in May 2016 and is headquartered in Brisbane, CA.

Vera Therapeutics Inc - Ordinary Shares - Class A

FDA accelerated approval of TRUTAKNA (atacicept) for adults with IgA nephropathy is the main catalyst, shifting attention to Veras commercial launch and the upcoming kidney-function data. Traders are divided between viewing the approval and high short interest as supportive for a squeeze, and arguing that the muted reaction reflects sell-the-news behavior and competitive pressure from rival therapies.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

India Smart Meters Market: Genus Power Unleashes 1.5

According to IMARC Group’s report titled “India Smart Meters Market Size, Share, Trends and Forecast by Product, Technology, End Use, and… Continue reading on Medium »

Genus Power Infrastructures Limited: Genus Power Surpasses 26 Million Smart Meter Deployment Worldwide, Reinforcing Leadership in End-to-End Advanced Metering Solutions

JAIPUR, India, March 2, 2026 /PRNewswire/ -- Genus Power (NSE: GENUSPOWER) (BSE: 530343), India's leading end-to-end energy measurement and advanced metering solutions provider, has crossed a sign...

Genus Power Surpasses 26 Million Smart Meter Deployment Worldwide, Reinforcing Leadership in End-to-End Advanced Metering Solutions

JAIPUR, India, March 2, 2026 /PRNewswire/ -- Genus Power (NSE: GENUSPOWER) (BSE: 530343), India's leading end-to-end energy measurement and advanced metering solutions provider, has crossed a significant milestone of over 26 million smart meter deployment worldwide, reinforcing its...

Genus Power Surpasses 1 Crore Smart Meter Milestone as India’s Smart Metering Mission Enters High-Scale Execution Phase

Genus Deploys 10 Million Smart Meters Across Nine States

Rajasthan-based smart metering solutions and service provider Genus Power has deployed 10 million smart meters under the Revamped Distribution Sector Scheme (RDSS) across nine states. Under RDSS, India aims to replace 250 million conventional meters with smart meters by 2028. In addition, another 15 million meters manufactured by Genus have been deployed through other advanced metering infrastructure service providers and utility partners, taking the total number of Genus smart meters operational in India to 25 million.

Brief TMT & Internet: Business Brain Showa Ota (9658 JP): Q3 FY03/26 flash update and more

In this briefing: Business Brain Showa Ota (9658 JP): Q3 FY03/26 flash update HK A+H IPO 2025 Cornerstone Lock-Up Expiry: Price and Liquidity Evidences Aequitas: PhonePe Pre-IPO - The Negatives - Near Term Growth Might Be Capped Broadleaf (3673 JP): Full-year FY12/25 flash update Genus Power Infrastructures Ltd - Q3 Sees Seasonal Moderation; Tendering Progress Will Be the Key 1. Business Brain Showa Ota (9658 JP): Q3 FY03/26 flash update In Q3 FY03/26, revenue rose to JPY31.1bn (+10.0% YoY), driven by Consulting and System Development (+14.8% YoY). Business income increased to JPY2.5bn (+11.6% YoY) with operating profit at JPY2.4bn (+11.2% YoY). BPO & Managed Services revenue grew to JPY7.5bn (+10.8% YoY), despite declines in HR payroll BPO and managed services. 2. HK A+H IPO 2025 Cornerstone Lock-Up Expiry: Price and Liquidity Evidences We examine H-share trading behavior around the six-month cornerstone lock-up expiry for A+H listings since 2025, assessing whether these events create systematic price pressure or primarily affect liquidity.

Brief TMT & Internet: HK A+H IPO 2025 Cornerstone Lock-Up Expiry: Price and Liquidity Evidences and more

In this briefing: HK A+H IPO 2025 Cornerstone Lock-Up Expiry: Price and Liquidity Evidences Aequitas: PhonePe Pre-IPO - The Negatives - Near Term Growth Might Be Capped Broadleaf (3673 JP): Full-year FY12/25 flash update Genus Power Infrastructures Ltd - Q3 Sees Seasonal Moderation; Tendering Progress Will Be the Key NetEase (NTES US) - 4Q25 Results: Strong Contract Liabilities Growth Despite Revenue Miss 1. HK A+H IPO 2025 Cornerstone Lock-Up Expiry: Price and Liquidity Evidences We examine H-share trading behavior around the six-month cornerstone lock-up expiry for A+H listings since 2025, assessing whether these events create systematic price pressure or primarily affect liquidity. We align each stock around its expiry date (T0) and analyze price and trading volume, incorporating both market-adjusted returns and a measure of overhang intensity relative to typical liquidity. Elevated trading activity emerges around expiry, but we find no consistent aggregate post-expiry underperformance; overhang intensity appears more linked to liquidity shifts than directional price moves. 2.

Brief India: Aequitas: PhonePe Pre-IPO - The Negatives - Near Term Growth Might Be Capped and more

In this briefing: Aequitas: PhonePe Pre-IPO - The Negatives - Near Term Growth Might Be Capped Pharmaceuticals: IPM: steady 11% growth in Jan-26 Man Infraconstruction Ltd - Q3FY26: Slower Momentum; Recovery Awaited Arvind SmartSpaces Ltd - Q3FY26: Execution-Led Growth with Strengthening BD Momentum Genus Power Infrastructures Ltd - Q3 Sees Seasonal Moderation; Tendering Progress Will Be the Key 1. Aequitas: PhonePe Pre-IPO - The Negatives - Near Term Growth Might Be Capped Phonepe (PPL) is looking to raise up to US$1.35bn in its upcoming India IPO. PhonePe Ltd (PPL) is a fintech firm that builds digital platforms for payments services, digital distribution and financial services, offering consumer payments, merchant payments and lending and insurance distribution services. In this note, we talk about the not-so-positive aspects of the deal. 2. Pharmaceuticals: IPM: steady 11% growth in Jan-26 As per IQVIA, IPM recorded strong growth for Jan-26 at 11% YoY (vs 15% in Dec-25), units grew by 1.1% YoY (4.4%% in Dec-25).

Brief TMT & Internet: Broadleaf (3673 JP): Full-year FY12/25 flash update and more

In this briefing: Broadleaf (3673 JP): Full-year FY12/25 flash update Genus Power Infrastructures Ltd - Q3 Sees Seasonal Moderation; Tendering Progress Will Be the Key NetEase (NTES US) - 4Q25 Results: Strong Contract Liabilities Growth Despite Revenue Miss Melco Holdings (6676 JP): Q3 FY03/26 flash update Freee (4478) 1. Broadleaf (3673 JP): Full-year FY12/25 flash update FY12/25 revenue rose 15.4% YoY to JPY20.8bn, with operating profit increasing 206.0% YoY to JPY2.1bn. FY12/26 forecasts: revenue JPY23.5bn (+12.9% YoY), operating profit JPY4.8bn (+132.7% YoY), dividend payout ratio 42.4%. Cloud services revenue increased 44.1% YoY; package system revenue declined 23.5% YoY due to cloud transition. 2. Genus Power Infrastructures Ltd - Q3 Sees Seasonal Moderation; Tendering Progress Will Be the Key Addressable Market: Against the RDSS’s Smart Meter Installation target of 25 Cr, ~15 Cr meters have been awarded, and 5.6 Cr are installed (~2.5 Cr meters are supplied by Genus). Out of the remaining 10 Cr meters to be awarded, tenders for 5 Cr meters are live; however, execution timelines in some large states, particularly Tamil Nadu (~3 Cr meters), may face delays of 4-6 months due to the election-related process.

Brief India: Pharmaceuticals: IPM: steady 11% growth in Jan-26 and more

In this briefing: Pharmaceuticals: IPM: steady 11% growth in Jan-26 Man Infraconstruction Ltd - Q3FY26: Slower Momentum; Recovery Awaited Arvind SmartSpaces Ltd - Q3FY26: Execution-Led Growth with Strengthening BD Momentum Genus Power Infrastructures Ltd - Q3 Sees Seasonal Moderation; Tendering Progress Will Be the Key Britannia Industries Ltd. - Margin Stability Powering a Sharper Growth Revival; Maintain BUY 1. Pharmaceuticals: IPM: steady 11% growth in Jan-26 As per IQVIA, IPM recorded strong growth for Jan-26 at 11% YoY (vs 15% in Dec-25), units grew by 1.1% YoY (4.4%% in Dec-25). Growth was led by CVS, anti-diabetes, CNS, VMN, and oncology segments, while growth in anti-infective, gastro, respiratory, derma, and pain grew at par or marginal below compared to IPM growth. Our view: IPM growth was steady at 11% YoY in Jan-26, largely led by price growth and traction in chronic therapies. Content is external broker report sourced from online content aggregator through publicly available sources and is displayed below for general informational purposes only.

Genus Power Infrastructures Ltd. is a holding company, which engages in the provision of metering and metering solutions. The firm operates through the Metering Business and Strategic Investment Activity segments. The Metering Business segment comprises of manufacturing and providing metering and metering solutions and undertaking engineering, construction and contracts on turnkey basis. The Strategic Investment Activity segment deals with strategic investments made in shares and securities. The company was founded on August 6, 1992 and is headquartered in Jaipur, India.

Current Price	352.00
Prev Close	332.00
Open	332.70
Dividend Yield	0.23%
50-Day Moving Average	318.43
Beta	0.14
Avg. Volume	3.17M
PE Ratio	14.85

52-Week High	358.95
52-Week Low	206.36
Market Capitalization	101.27B
EPS (Annual)	21.42
Price to Book	5.08
Revenue Per Employee	N/A

Feed

News

Sentiment

Fundamentals

Info